Medicare Enrolled
Dr. Vladislav Bargman, M.D.
Urology Physician · Palm Springs, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bargman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bargman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bargman
Dr. Vladislav Bargman is an urology physician in Palm Springs, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bargman performed 1,942 Medicare services across 1,521 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bargman received a total of $5,076 from 43 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bargman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 41% volume in CA
$5,076 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,942
Medicare services
Top 41% in CA for urology physician
1,521
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
531 | $70 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
261 | $125 | $450 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
238 | $47 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
203 | $101 | $376 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
186 | $9 | $60 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
91 | $122 | $1,200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $46 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
55 | $196 | $850 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
33 | $26 | $650 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $138 | $650 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
30 | $29 | $90 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $309 | $1,200 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $6 | $75 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
19 | $29 | $75 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $52 | $240 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
18 | $27 | $300 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $164 | $850 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
18 | $133 | $10,000 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $12 | $45 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $25 | $200 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $104 | $700 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
13 | $64 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,076
Total received (2018-2024)
Avg $725/year across 7 years
Top 33% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,076 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,673
2023
$1,750
2022
$754
2021
$386
2020
$368
2019
$30
2018
$115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$247
UROGEN PHARMA, INC.
$200
Calyxo, Inc.
$195
COLOPLAST CORP
$159
Axonics, Inc.
$152
INTUITIVE SURGICAL, INC.
$131
Sumitomo Pharma America, Inc.
$103
Boston Scientific Corporation
$84
IMMUNITYBIO, INC.
$83
Abbott Laboratories
$73
ACCORD HEALTHCARE, INC.
$37
Astellas Pharma US Inc
$37
Olympus America Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$28
Myriad Genetic Laboratories, Inc.
$28
PFIZER INC.
$24
Becton, Dickinson and Company
$22
Ferring Pharmaceuticals Inc.
$19
Davol Inc.
$19
Top 3 companies account for 38.4% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$611
Boston Scientific Corporation
$463
Axonics, Inc.
$375
Sumitomo Pharma America, Inc.
$365
Integra LifeSciences Corporation
$245
Abbott Laboratories
$235
UROGEN PHARMA, INC.
$200
BIOTISSUE HOLDINGS, INC.
$196
Calyxo, Inc.
$195
PALETTE LIFE SCIENCES, INC.
$173
Myriad Genetic Laboratories, Inc.
$171
Laborie Medical Technologies Corp.
$167
COLOPLAST CORP
$159
Coloplast Corp
$140
Olympus America Inc.
$133
INTUITIVE SURGICAL, INC.
$131
Astellas Pharma US Inc
$116
IMMUNITYBIO, INC.
$83
Myovant Sciences Inc.
$81
UROVANT SCIENCES INC
$78
MAYNE PHARMA COMMERCIAL LLC
$67
PROCEPT BioRobotics Corporation
$56
ACCORD HEALTHCARE, INC.
$56
180 Medical, Inc.
$54
Janssen Biotech, Inc.
$50
UroGen Pharma, Inc.
$48
C. R. Bard, Inc. & Subsidiaries
$42
TOLMAR Pharmaceuticals, Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$32
Baxter Healthcare
$32
AbbVie, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
AbbVie Inc.
$27
Amgen Inc.
$26
PFIZER INC.
$24
Becton, Dickinson and Company
$22
Blue Earth Diagnostics Limited
$20
Ferring Pharmaceuticals Inc.
$19
Davol Inc.
$19
Agile Therapeutics, Inc.
$19
Supernus Pharmaceuticals, Inc.
$19
Antares Pharma, Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$14
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Axonics · Axonics r-SNM System · Axumin · BIOFIX · Bard Urinary Drainage Bag · BioSurgery - TISSEEL · CAMCEVI · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ELIGARD · ERLEADA · EVENITY · GEMTESA · GENERAL - THERAPIES · GentleCath · Isiris aStent Removal Device · JELMYTO · LUPRON DEPOT · Luja Coude · Lupron · Lupron Depot · MEDIHONEY · MYRBETRIQ · NEOX · Nubeqa · ORGOVYX · PROCLAIM · PROLARIS · Proclaim Family of SCS IPGs · Prolaris · REZUM · Rezum Generator · SOLESTA · SPACEOAR · ShockPulse - SE · SpaceOAR System · SpeediCath · TLANDO · Titan · Twirla · UROLIFT · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
18
Per 100K population
0.7
County median income
$89,672
Nearest hospital
DESERT REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bargman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bargman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bargman performed 531 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bargman receive payments from pharmaceutical companies?
Yes. Dr. Bargman received a total of $5,076 from 43 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bargman's costs compare to other urology physicians in Palm Springs?
Dr. Bargman's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bargman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Palm Springs
Browse urology physicians in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology